SYZ CELL THERAPY CO has a total of 28 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are CHILDREN S HOSPITAL OF EASTERN ONTARIO RES INST INC, NOUSCOM AG and CHECKMATE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | China | 3 | |
#4 | Taiwan | 3 | |
#5 | United States | 3 | |
#6 | Republic of Korea | 2 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | Hong Kong | 1 | |
#10 | Israel | 1 | |
#11 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Zhou Xiangjun | 26 |
#2 | Han Yanyan | 23 |
#3 | Li Jin | 16 |
#4 | Liu Junyun | 15 |
#5 | Wu Dongyun | 15 |
#6 | Tang Longqing | 14 |
#7 | Tao Ran | 9 |
#8 | Chen Xihe | 8 |
#9 | Liang Xiaoling | 8 |
#10 | Ma Yifan | 5 |
Publication | Filing date | Title |
---|---|---|
WO2019196088A1 | Methods of obtaining tumor-specific t cell receptors | |
WO2019196087A1 | Methods of cancer treatment using tumor antigen-specific t cells | |
WO2019183924A1 | Improved multiple antigen specific cell therapy methods | |
WO2016145578A1 | Methods of cancer treatment using activated t cells |